These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2519871)

  • 1. Tissue concentrations of doxorubicin in animal models with engrafted intraocular tumours.
    White L; Chan KK; Barrientos A; Gomer CJ; Murpheree AL; Benedict WF
    In Vivo; 1989; 3(5):315-7. PubMed ID: 2519871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of retinoblastoma to local diaziquone. Studies in a xenograft model.
    White L
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):787-91. PubMed ID: 2335447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterotransplantation of retinoblastoma into the athymic "nude" mouse.
    Gallie BL; Albert DM; Wong JJ; Buyukmihci N; Pullafito CA
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):256-9. PubMed ID: 844983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in retinoblastoma: current status and future directions.
    White L
    Am J Pediatr Hematol Oncol; 1991; 13(2):189-201. PubMed ID: 2069230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cyclophosphamide and diaziquone in a retinoblastoma xenograft model.
    White L; Reed C; Tobias V
    Ophthalmic Paediatr Genet; 1989 Jun; 10(2):99-105. PubMed ID: 2779985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of 3H-hematoporphyrin derivative in athymic "nude" mice heterotransplanted with human retinoblastoma.
    Gomer CJ; Rucker N; Mark C; Benedict WF; Murphree AL
    Invest Ophthalmol Vis Sci; 1982 Jan; 22(1):118-20. PubMed ID: 7056618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor regression of human retinoblastoma in the nude mouse following photoradiation therapy: a preliminary report.
    Benedict WF; Lingua RW; Doiron DR; Dawson JA; Murphree AL
    Med Pediatr Oncol; 1980; 8(4):397-401. PubMed ID: 7453671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice.
    White L; Szirth BC; Benedict WF
    Cancer Chemother Pharmacol; 1989; 23(2):63-7. PubMed ID: 2910512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterotransplantation of the SO-Rb50 cell line into athymic "nude" mice].
    Feng GG; Li YP; Yi YZ
    Zhonghua Yan Ke Za Zhi; 1994 Jan; 30(1):47-9. PubMed ID: 8082477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.
    Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Br J Cancer; 2001 Feb; 84(4):550-7. PubMed ID: 11207053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and characteristics of a model of nude mouse xenograft of human retinoblastoma].
    Yi X; Ni Z; Wang W
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):145-8. PubMed ID: 7656725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
    Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
    Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-selective prodrug activation by fusion protein-mediated catalysis.
    Bosslet K; Czech J; Hoffmann D
    Cancer Res; 1994 Apr; 54(8):2151-9. PubMed ID: 8174122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo.
    Howard MA; Wardwell S; Albert DM
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1711-3. PubMed ID: 2032794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations.
    DeGregorio MW; Dingley KH; Wurz GT; Ubick E; Turteltaub KW
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):335-42. PubMed ID: 16047147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model.
    White L; Gomer CJ; Doiron DR; Szirth BC
    Br J Cancer; 1988 May; 57(5):455-8. PubMed ID: 3395551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic retinoblastoma and L-phenylalanine mustard-dianhydrogalactitol.
    Helson L; Kitchin FD; Abramson D; Ellsworth RM
    Anticancer Res; 1982; 2(4):235-8. PubMed ID: 7149653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.